Table 2 Operative details
From: Lymphadenectomy in ovarian cancers: a meta-analysis of hazard ratios from randomized clinical trials
Parameters | Harter ( 2019) | Panici 2005 | Maggioni 2006 | ||||||
|---|---|---|---|---|---|---|---|---|---|
Case N=323 n (%) | Control N=324 n (%) | P value | Case N=216 n (%) | Control N=211 n (%) | P value | Case N=138 n (%) | Control N=130 n (%) | P value | |
Median operating time (min) | 340 | 280 | <0.001 | 300 | 210 | <0.001 | 240 | 150 | < 0.001 |
Median blood loss (ml) | 650 | 500 | <0.001 | 1000 | 650 | <0.001 | 600 | 300 | < 0.001 |
Patients transfused (%) | 63.7 | 56 | 0.005 | 71.7 | 59.2 | 0.006 | 35.5 | 21.85 | 0.012 |
Median hospital stay (days) | - | - | - | 9 | 9 | 0.21 | 7 | 6 | 0.003 |
Postoperative admission to immediate or intensive care unit( %) | 77.6 | 69 | 0.001 | - | - | - | - | - | - |
Infections treated with antibiotics (%) | 25.8 | 18.6 | 0.03 | - | - | - | - | - | - |
Lymph cysts | 24 (7.4) | 1 (0.3) | < 0.001 | 14 (0.06) | 0 | - | 8 (0.020 | 0 | - |
Repeat laparotomies for complications (%) | 12.4 | 6.5 | 0.001 | NM | NM | - | NM | NM | - |
Death within 60 days | 10 (3.1) | 3 (0.9) | 0.004 | 0 | 0 | - | 0 | 0 | - |
Postoperative systemic treatment | 277 (85.7) | 279 (86.1) | 0.2 | 207 (960 | 198 (94) | 0.3 | 77 (56) | 78 (66) | 0.11 |